Guangdong Taienkang Pharmaceutical Co., Ltd. (also known as "T&K") was founded in 1999 and is a new OTC market listed company (stock code: 831173). At present, the company has 6 wholly-owned subsidiaries and 3 holding subsidiaries. T&K have an operation outlet that reaches 28 provincial regions across China, forming a sales channel network and sales team covering thousands of hospitals and more than 70,000 pharmacies. 

T&K aim to provide an R&D platform for domestic and foreign pharmaceutical products and medical devices, as well as a platform for the production and sales of proprietary Chinese herbal medicines, external-use medicines, medical devices, and sanitary materials, etc.